Certified by Founder Lodge
NanoPhoria
Italy - Milan, Lombardy
START UP
1 Disclosed Funding Rounds $97,716,710
0 Participating Investments
-
Founded date
2022
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
NanoPhoria is a preclinical stage biotech company pioneering inhalable cardiovascular treatments via non-viral nano-delivery of biologics.
The Company is devoted to the clinical developmen
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| October, 07 ,2025 | Series A | $97,716,710 |
Panakes Partners
XGEN Venture
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
Cirrus Therapeutics | $11,000,000 | (Oct 7, 2025)
Ansa Biotechnologies, Inc. | $54,400,000 | (Oct 7, 2025)
kiutra | $15,206,295 | (Oct 7, 2025)
Voltai | $1,311,818 | (Oct 7, 2025)
